Functional investigations
of the cloned PDR2 construct. The sequence section of
the pBR322 plasmid with homologies to the mammalian U6 promoter was
subcloned into the multiple cloning site of pUC18 and subsequently
analysed by transcription experiments in vitro.
(A) Dependence of the PDR2 clone on TBP-DR2.
A transcription system, based on phosphocellulose fractions PCB
and PCC (lanes 1–7), corresponding to the reconstituted
transcription system shown in Figure 1, was supplemented either
with TBPwt (lanes 2–4; 5, 10 and 20 ng) or TBP-DR2 (lanes
5–7; 5, 10 and 20 ng). Lane 1 shows the control sample
without additional recombinant human TBP. The asterisk indicates
the TBP-DR2 dependent vector transcript of ∼320
nt. The transcript resulting from the subcloned promoter is marked
by PDR2. (B) α-Amanitin
characterisation of the PDR2 transcription in
vitro. Three identical transcription samples contained 10 µl PCB, 20 µl PCC,
10 ng recombinant human TBP-DR2 and 1 µg
pUPDR2 as template. The control sample without the inhibitor α-amanitin is shown in lane 1. The samples shown
in lanes 2 and 3 contained α-amanitin
at a concentration of 2 and 300 µg/ml
respectively. The PDR2 transcript is appropriately indicated.
The signal at the bottom of the gel represents tRNA contained as
a carrier.